Gene Logic Licenses BioCarta Signal Transduction Data For Use in GeneExpress | GenomeWeb

NEW YORK, Nov. 27—Gene Logic said Tuesday that it had obtained an exclusive commercial license that will add BioCarta's signal transduction pathway information to its software and database products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.